A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria

NCT06819826 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

IgA Nephropathy (IgAN)

Interventions

DRUG: SC0062 strength 10mg
DRUG: Placebo matched to SC0062

Sponsor

Biocity Biopharmaceutics Co., Ltd.